Anthropic is cutting Claude subscription access for third-party tools like OpenClaw starting April 4th, forcing users onto a pay-as-you-go model while offering a one-time credit and discounted bundles as compensation.
Oracle slashes 10,000 jobs in India — roughly 20% of its local workforce — as part of a sweeping global restructuring affecting 30,000 employees worldwide, with analysts saying the cuts could free up $10 billion to fuel the tech giant's aggressive AI and data centre expansion.
Sandisk drops 26% amid fears over Google's TurboQuant compression algorithm, but with Q2 data center sales surging 64% quarter-over-quarter, margins projected at 65-67%, and a $671 price target suggesting 17-18% undervaluation, analysts say the sell-off is overblown and the stock presents a strong buying opportunity.
OpenAI is gearing up to release a new AI model code-named 'Spud' while simultaneously pushing wealth redistribution policies, restructuring internally, and planning a 2026 IPO, as CEO Sam Altman works to reshape the social contract around artificial intelligence.
AI seed startups are commanding sky-high valuations in 2026, with $10M rounds now closing at $40–$45M post-money as elite founders, rapid traction, and fierce VC competition drive prices up — but inflated early valuations are raising the stakes for founders who must scale fast or face serious consequences.
Oracle is cutting thousands of jobs amid a 25% stock drop and mounting debt, as the tech giant bets big on AI infrastructure with plans to raise $50 billion and honor a $300 billion OpenAI deal, while analysts say slashing up to 30,000 employees could unlock $10 billion in free …
OpenAI launches enterprise-focused Codex plugins integrating Google Drive, GitHub, and Slack, while simultaneously shutting down Sora, ending its $1 billion Disney deal, and pausing adult content plans as the company aggressively pivots toward IPO readiness and a 50-50 consumer-to-enterprise revenue split.
Eli Lilly signs a landmark $2.75 billion deal with AI drug pioneer Insilico Medicine, offering $115 million upfront to fast-track AI-generated drugs across multiple disease areas into global markets.
A new benchmark called FinMCP-Bench launches to rigorously test AI models on real-world financial problem-solving, featuring 613 samples, 65 real financial tools, and 33 sub-scenarios designed to measure both tool invocation accuracy and reasoning capabilities across mainstream large language models.
AI inference costs are set to plummet over 90% by 2030, but total spending will surge as agentic AI models consume dramatically more tokens per task, forcing companies to strategically route workloads or risk falling into a costly commoditization trap.